Why do heavy protein shakes cause stomach pain on GLP-1s
[1] Dose-escalation studies, such as a 12-week trial on gradual titration, revealed that beginning at lower doses (e.g., 4 mg) and slowly increasing to therapeutic levels significantly reduced the incidence of nausea, vomiting, and diarrhoea
As manufacturers direct-to-consumer alternatives have expanded, the cash-pay prices for obesity products have decreased considerably
GLP-1 (glucagon-like peptide-1) medications are powerful tools in the fight against chronic weight management and metabolic challenges
Enhanced formulation approach: When using cyclodextrin or other absorption enhancers, lower doses of 0.25-0.5mg per actuation may be sufficient due to improved bioavailability
Mol Ther Nucleic Acids (2020) 23:61428